Schiff Center for Liver Diseases/University of Miami — Miami, Florida

Schiff Center for Liver Diseases/University of Miami is a clinical research site located in Miami, Florida, United States 33136.

Crixeo Clinical Trials Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.

Schiff Center for Liver Diseases/University of Miami has participated in 33 clinical trials with 11 currently active.

Therapeutic areas: Compensated Cirrhosis, Nonalcoholic Steatohepatitis, Hepatocellular Cancer.

Sponsors: Intercept Pharmaceuticals, Target PharmaSolutions, Inc., Gilead Sciences.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Miami

Browse all research sites in Florida · View every site in Miami

Sponsor Feasibility Report

Trust Score: 86/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Schiff Center for Liver Diseases/University of Miami?

Schiff Center for Liver Diseases/University of Miami has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Schiff Center for Liver Diseases/University of Miami conducted?

Schiff Center for Liver Diseases/University of Miami has 33 clinical trials on record, with 11 currently active. Their work covers Compensated Cirrhosis, Nonalcoholic Steatohepatitis, Hepatocellular Cancer.

Is Schiff Center for Liver Diseases/University of Miami accredited by Crixeo Clinical Trials?

Schiff Center for Liver Diseases/University of Miami has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Schiff Center for Liver Diseases/University of Miami?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.